BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 18800213)

  • 21. The role of classic risk factors and prothrombotic factor gene mutations in ischemic stroke risk development in young and middle-aged individuals.
    Supanc V; Sonicki Z; Vukasovic I; Solter VV; Zavoreo I; Kes VB
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):e171-6. PubMed ID: 24189452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do thrombophilic gene mutations have a role on thromboembolic events in cancer patients?
    Ozkan M; Sivgin S; Kocyigit I; Emirogullari F; Dikilitas M; Kaynar L; Ozkul Y; Er O
    Asia Pac J Clin Oncol; 2012 Sep; 8(3):e34-41. PubMed ID: 22898008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of thrombophilic genetic factors on pulmonary embolism: early onset and recurrent incidences.
    Ivanov P; Komsa-Penkova R; Kovacheva K; Ivanov Y; Stoyanova A; Ivanov I; Pavlov P; Glogovska P; Nojarov V
    Lung; 2008; 186(1):27-36. PubMed ID: 18097719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Superficial venous thrombosis: prevalence of common genetic risk factors and their role on spreading to deep veins.
    Milio G; Siragusa S; Minà C; Amato C; Corrado E; Grimaudo S; Novo S
    Thromb Res; 2008; 123(2):194-9. PubMed ID: 18387654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ocular vascular thrombotic events: a diagnostic window to familial thrombophilia (compound factor V Leiden and prothrombin gene heterozygosity) and thrombosis.
    Glueck CJ; Wang P
    Clin Appl Thromb Hemost; 2009 Feb; 15(1):12-8. PubMed ID: 18796459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Contributions of Thrombophilic Mutations to Genetic Susceptibility to Deep Venous Thrombosis in Iraqi Patients.
    Al-Allawi NA; Badi AI; Goran MA; Nerweyi FF; Ballo HM; Al-Mzury NT
    Genet Test Mol Biomarkers; 2015 Sep; 19(9):500-4. PubMed ID: 26196588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Massive pulmonary embolism associated with Factor V Leiden, prothrombin, and methylenetetrahydrofolate reductase gene mutations in a young patient on oral contraceptive pills: a case report.
    Charafeddine KM; Mahfouz RA; Ibrahim GY; Taher AT; Hoballah JJ; Taha AM
    Clin Appl Thromb Hemost; 2010 Oct; 16(5):594-8. PubMed ID: 19520679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebral venous and sinus thrombosis and thrombophilic mutations in Western Iran: association with factor V Leiden.
    Rahimi Z; Mozafari H; Bigvand AH; Doulabi RM; Vaisi-Raygani A; Afshari D; Razazian N; Rezaei M
    Clin Appl Thromb Hemost; 2010 Aug; 16(4):430-4. PubMed ID: 19703820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Who are at risk for thromboembolism after arthroplasty? A systematic review and meta-analysis.
    Zhou X; Qian W; Li J; Zhang P; Yang Z; Chen W; Wu L
    Thromb Res; 2013 Nov; 132(5):531-6. PubMed ID: 24074702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic susceptibility to pregnancy-related venous thromboembolism: roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations.
    Grandone E; Margaglione M; Colaizzo D; D'Andrea G; Cappucci G; Brancaccio V; Di Minno G
    Am J Obstet Gynecol; 1998 Nov; 179(5):1324-8. PubMed ID: 9822524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The 19-bp deletion of dihydrofolate reductase (DHFR), methylenetetrahydrofolate reductase (MTHFR) C677T, Factor V Leiden, prothrombin G20210A polymorphisms in cancer patients with and without thrombosis.
    Eroglu A; Egin Y; Cam R; Akar N
    Ann Hematol; 2009 Jan; 88(1):73-6. PubMed ID: 18682947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PLA2 polymorphism of platelet glycoprotein IIb/IIIa but not Factor V Leiden and prothrombin G20210A polymorphisms is associated with venous thromboembolism and more recurrent events in central Iran.
    Pourgheysari B; Boroujeni HR; Hasheminia AM; Drees F
    Blood Coagul Fibrinolysis; 2013 Jul; 24(5):471-6. PubMed ID: 23358226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.
    Lijfering WM; Middeldorp S; Veeger NJ; Hamulyák K; Prins MH; Büller HR; van der Meer J
    Circulation; 2010 Apr; 121(15):1706-12. PubMed ID: 20368522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Major and potential prothrombotic genotypes in patients with venous thrombosis and in healthy subjects from Slovenia.
    Bedencic M; Bozic M; Peternel P; Stegnar M
    Pathophysiol Haemost Thromb; 2008; 36(2):58-63. PubMed ID: 19127083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in 200 healthy Jordanians.
    Eid SS; Rihani G
    Clin Lab Sci; 2004; 17(4):200-2. PubMed ID: 15559724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of deep venous thrombosis with prothrombotic gene polymorphism identified in lung cancer cases.
    Arslan S; Manduz S; Epöztürk K; Karahan O; Akkurt I
    Mol Biol Rep; 2011 Apr; 38(4):2395-400. PubMed ID: 21080081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of plasminogen activator inhibitor-1 polymorphism, factor-V-Leiden, and prothrombin-20210 mutations in pulmonary thromboembolism.
    Oguzulgen IK; Yilmaz E; Demirtas S; Erkekol FO; Ekim N; Demir N; Numanoglu N; Ozel D; Ulu A; Akar N
    Clin Appl Thromb Hemost; 2009 Feb; 15(1):73-7. PubMed ID: 18160588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombophilic Gene Mutations in Relation to Different Manifestations of Venous Thromboembolism: A Single Tertiary Center Study.
    Bezgin T; Kaymaz C; Akbal Ö; Yılmaz F; Tokgöz HC; Özdemir N
    Clin Appl Thromb Hemost; 2018 Jan; 24(1):100-106. PubMed ID: 27729560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation on genetic thrombophilic factors in FFPE autopsy tissue from subjects who died from pulmonary embolism.
    Brandimarti F; Alessandrini F; Pesaresi M; Catalani C; De Angelis L; Galeazzi R; Giovagnetti S; Gesuita R; Righi E; Giorgetti R; Tagliabracci A
    Int J Legal Med; 2017 Mar; 131(2):447-458. PubMed ID: 27933413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.